Abiopharma

News list

Director Henry Andrew Chisholm 🟢 acquired 668 shares of TERADYNE, INC (TER) Transaction Date: May 08, 2026 | Filing ID: 000262

Full text

News bot May 12, 2026, 9:06 p.m.
🔍 Henry Andrew Chisholm (Director)

Company: TERADYNE, INC (TER)

Report Date: 2026-05-08
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 668
Detailed Transactions and Holdings:
- Acquired 668 shares of Common Stock (Direct)
  Date: 2026-05-08 | Code: A | equity_swap_involved: 0 | shares_owned_after: 2,875.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: Represents restricted stock units ("RSUs") granted to the Reporting Person under the Issuer's 2006 Equity and Cash Compensation Incentive Plan. Each RSU represents the right to receive one share of Common Stock. The RSUs are time-based, and will vest in full on the earlier of May 8, 2027 or the date of the Issuer's 2027 Annual Meeting of Shareholders.